DOJ Joins SEC’s Investigation of Pharmaceutical Company Alexion

Alexion

On November 2, Alexion Pharmaceutical Inc. disclosed that the Department of Justice had requested documents and other information related to the company’s compliance with the FCPA.  The Securities and Exchange Commission is also investigating the company’s compliance with the FCPA, a fact that Alexion disclosed in May.  The SEC’s subpoena sought information about Alexion’s grant-making activities worldwide, specifically naming Japan, Brazil, Turkey and Russia in its request, and also addressed non-FCPA items. The drugmaker said that it planned to cooperate with DOJ’s investigation.